Published in Blood Weekly, June 17th, 1996
Both organizations contribute scientific expertise, manpower and technology towards product development and HemaSure would commercialize products resulting from the collaboration.
Areas of collaboration are expected to include:
pathogen inactivation systems for blood components and plasma for transfusion;
development of state-of-the-art blood filters, including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.